KVUE vs STZ
KVUE: The world's largest pure-play consumer health company, leveraging a portfolio of iconic brands like Tylenol, Listerine, and Neutrogena across self-care, skin health, and essential health categories. STZ: International beverage alcohol producer with dominant U.S. beer portfolio anchored by #1 brand Modelo Especial and premium wine and spirits brands.
Side-by-side fundamentals
| Metric | KVUE | STZ | Edge |
|---|---|---|---|
| Price as of 2026-07-10 close | $19.48 | $134.06 | |
| Market cap as of 2026-07-12 | $37.4B | $22.9B | |
| P/E as of 2026-07-12 | 23.06 | 12.55 | STZ lower |
| PEG as of 2026-07-12 | 2.72 | 4.89 | KVUE lower |
| Net margin as of 2026-07-12 | +10.6% | +20.1% | STZ higher |
| Gross margin as of 2026-07-12 | +58.9% | +52.8% | KVUE higher |
| Operating margin as of 2026-07-12 | +17.1% | +31.5% | STZ higher |
| ROE as of 2026-07-12 | +15.2% | +23.1% | STZ higher |
| ROA as of 2026-07-12 | +6.0% | +8.4% | STZ higher |
| Debt / equity as of 2026-07-12 | 0.82 | 1.28 | KVUE lower |
| Revenue growth (YoY) as of 2026-07-12 | -0.1% | -10.0% | KVUE higher |
| Revenue CAGR (3y) SEC XBRL | +0.2% | -1.1% | KVUE higher |
| Dividend yield as of 2026-07-12 | +4.3% | +3.1% | KVUE higher |
| Dividend streak (yrs) SEC XBRL | 3 | n/a | |
| Beta as of 2026-07-12 | 0.46 | 0.40 | |
| 1-year return as of 2026-07-10 close | -6.9% | -22.1% | KVUE higher |
Fundamentals: Finnhub, as of 2026-07-12. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.